NEWARK, Del, March 06, 2024 (GLOBE NEWSWIRE) -- The immuno-oncology assay market is anticipated to reach US$ 18.1 billion in 2034, from an estimated US$ 5.6 billion in 2024. The industry is projected ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results